Polyphenols as Promising Drugs against Main Breast Cancer Signatures
Breast cancer is one of the most common neoplasms worldwide, and in spite of clinical and pharmacological advances, it is still a clinical problem, causing morbidity and mortality. On the one hand, breast cancer shares with other neoplasms some molecular signatures such as an imbalanced redox state,...
Main Authors: | María Losada-Echeberría, María Herranz-López, Vicente Micol, Enrique Barrajón-Catalán |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/6/4/88 |
Similar Items
-
Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
by: Atif Ali Hashmi, et al.
Published: (2018-01-01) -
MYC-Driven Pathways in Breast Cancer Subtypes
by: Yassi Fallah, et al.
Published: (2017-07-01) -
Classifying Breast Cancer Metastasis Based on Imaging of Tumor Primary and Tumor Biology
by: Barbara Awad, et al.
Published: (2023-01-01) -
Intestinal polyphenol antioxidant activity involves redox signaling mechanisms facilitated by aquaporin activity
by: Kaiwen Mu, et al.
Published: (2023-12-01) -
Targeting pancreatic beta cell death in type 2 diabetes by polyphenols
by: Ana García-Aguilar, et al.
Published: (2022-11-01)